|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| Jul. 15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| Jul. 15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
| Market Cap | 266B 329B 288B 245B 462B 31,750B 472B 3,181B 1,250B 15,552B 1,238B 1,211B 53,563B | P/E 2026 * |
17.9x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 277B 343B 300B 255B 480B 33,008B 491B 3,307B 1,300B 16,168B 1,288B 1,259B 55,685B | EV / Sales 2026 * |
4.43x | EV / Sales 2027 * | 4.14x |
| Free-Float |
88.78% | Yield 2026 * |
3% | Yield 2027 * | 3.07% |
Last Transcript: Roche Holding AG
| Current month | +0.48% | ||
| 6 months | -6.53% | ||
| Current year | -1.29% |
| Current year | 311.6 |  | 377 |
| 1 year | 221.3 | | 377 |
| 3 years | 212.3 | | 377 |
| 5 years | 212.3 | | 404.1 |
| 10 years | 202.23 | | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 330B | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| -0.36% | +3.64% | +2.37% | -30.88% | 143B | |
| Average | -0.18% | +1.02% | +25.55% | +47.80% | 376.38B | |
| Weighted average by Cap. | +0.27% | +0.25% | +36.83% | +80.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.6B 77.4B 67.73B 57.56B 108B 7,459B 111B 747B 294B 3,653B 291B 285B 12,583B | 65.29B 80.73B 70.63B 60.03B 113B 7,779B 116B 779B 306B 3,810B 303B 297B 13,123B |
| Net income | 15.22B 18.83B 16.47B 14B 26.39B 1,814B 26.99B 182B 71.44B 889B 70.76B 69.2B 3,060B | 16.35B 20.21B 17.69B 15.03B 28.33B 1,948B 28.98B 195B 76.71B 954B 75.98B 74.31B 3,286B |
| Net Debt | 10.56B 13.05B 11.42B 9.71B 18.29B 1,258B 18.71B 126B 49.53B 616B 49.06B 47.98B 2,122B | 3.92B 4.84B 4.24B 3.6B 6.79B 467B 6.94B 46.73B 18.37B 229B 18.2B 17.8B 787B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | CHF 323.90 | 0.00% | 929 |
| 26-07-16 | CHF 323.90 | 0.00% | 314 |
| 26-07-15 | CHF 323.90 | 0.00% | 1,443 |
| 26-07-14 | CHF 323.90 | 0.00% | 566 |
| 26-07-13 | CHF 323.90 | 0.00% | 111 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions
